Januzzi, J. L., Gibson, C. M., Chi, G., Coller, B. S., Granger, C. B., Montalescot, G., Rikken, S. A. O. F., Verburg, A., Berg, J. M. T., & van 't Hof, A. W. J. (2026). The effect of zalunfiban on high sensitivity cardiac troponin and the association with clinical outcomes in patients with STEMI. American Heart Journal, 301, Article 107513. https://doi.org/10.1016/j.ahj.2026.107513

Wu, Y., & ten Cate, H. (2026). Shiver me timbers: cold-driven lipids fuel platelet production. Cell Research, 36(9), 641-642. https://doi.org/10.1038/s41422-026-01265-1

Wang, S. J., van Meel, R. A. J. N., Mestrum, S. G. C., Habets, T. H. P. M., Hopman, A. H. N., Ramaekers, F. C. S., Henskens, Y. M. C., Bekers, O., & Leers, M. P. G. (2026). Functional Characterization of Myelodysplastic Syndrome by Multiparameter Flow Cytometry: The Clinical Synergy Between Ki-67 and Bcl-2 and Their Potential Role in Diagnostics and Personalized Therapy. Cancers, 18(16), Article 2648. https://doi.org/10.3390/cancers18162648

Peeters, D. A. M., Woelders, E. C. I., Janssen, S., Azzahhafi, J., Yin, D. R. P. P. C. P., van den Broek, W. W. A., Winkler, P. J. C., van de Pol, Q. Y. F., Cetinyurek-Yavuz, A., Damman, P., Luijkx, J. J. P., Remkes, W. S., van't Hof, A. W. J., ten Berg, J. M., & van Geuns, R. J. M. (2026). Lipid-lowering therapy omission at discharge and one-year outcomes after percutaneous coronary intervention: a real-world analysis of overall and elderly patients. IJC Heart and Vasculature, 65, Article 101961. https://doi.org/10.1016/j.ijcha.2026.101961

Bondi, E., Obino, G., Guidotti, G., Sensini, A., Nagy, M., Spronk, H. M. H., van Griensven, M., Lepedda, A. J., Lotti, N., & Moroni, L. (2026). Aromatic Copolyesters Based on Poly(butylene furanoate) and Poly(butylene isophthalate) for Small-Diameter Vascular Applications. ACS Biomaterial Science and Engineering, 12(7), 3557-3568. https://doi.org/10.1021/acsbiomaterials.6c00106

Stroobants, A. K., Gottgens, E.-L., Henskens, Y. M. C., Jansen, J. H., Schols, S. E. M., & Rijpma, S. R. (2026). Monitoring Extended Half-Life Factor VIII and IX Concentrates: Performance in Routine Clotting-and Thrombin Generation Assays. Haemophilia, 32(4), 1002-1015. https://doi.org/10.1111/hae.70300

van Dam, A. D., Bioch, M. M., Jeninga, E. H., de Kok, J. B., Rijpma, S. R., Thelen, M. H. M., Henskens, Y. M. C., van Oerle, R. G. M., Stroobants, A. K., & Coagulation Section of the Dutch Foundation for Quality Assessment in Medical Laboratory Diagnostics (SKML) (2026). Pre-analytical storage and reagent-dependent sensitivity as sources of variability in prothrombin time and activated partial thromboplastin time measurements. Thrombosis Research, 263, Article 109771. https://doi.org/10.1016/j.thromres.2026.109771

Derikx, F., Merry, I., Willemsen, D., Beckers, E., Henskens, Y., & Heubel-Moenen, F. (2026). A Rare Combination of von Willebrand Disease Type 2A and 2M: Diagnostic and Therapeutic Challenges – A case report. Research and practice in thrombosis and haemostasis, 10(5), Article 106867. https://doi.org/10.1016/j.rpth.2026.106867

Galli, M., Simeone, B., ten Berg, J., Capodanno, D., Valgimigli, M., Sciarretta, S., Greco, E., Kastrati, A., Montalescot, G., Gibson, C. M., Gorog, D. A., Mehran, R., & Angiolillo, D. J. (2026). Managing bleeds on anticoagulant therapy: a practical guide for clinicians. European Heart Journal: Acute Cardiovascular Care, 15(7), 557-572. Article zuag035. https://doi.org/10.1093/ehjacc/zuag035

Franssen, I. S., de Jong, M. J., Visseren, L., Teerds, D., Hellenbrand, D., Henskens, Y., Spronk, H., Janssen, D. J. A., Braeken, D. C. W., van Kuijk, S. M. J., Winckers, K., & Magdelijns, F. J. H. (2026). The DOAC-FRAIL Study-Same Dose, Different Story: Prevalence of Deviant Direct Oral Anticoagulant Levels in Nursing Home Residents. Journal of the American Geriatrics Society. Advance online publication. https://doi.org/10.1111/jgs.70559

Erdoes, G., Koster, A., Shore-Lesserson, L., Vilnits, Y., Steiner, M. E., ten Cate, H., & Mazzeffi, M. (2026). The Year in Coagulation and Transfusion: Selected Highlights. Journal of Cardiothoracic and Vascular Anesthesia, 40(7), 1939-1945. https://doi.org/10.1053/j.jvca.2026.03.005

Rocca, B., & ten Cate, H. (2026). Antidotes for Anticoagulation Reversal. New England Journal of Medicine, 394(22), 2235-2254. https://doi.org/10.1056/NEJMra2506021

Schellens, J., Nagy, M., Hulshof, A. M., van Rosmalen, F., van Oerle, R., van Herpt, T. T. W., Alnima, T., Mulder, M. M. G., Hellenbrand, D., ten Cate, H., Driessen, R. G. H., Sels, J. W. E. M., van der Horst, I. C. C., Henskens, Y. M. C., van Bussel, B. C. T., Spronk, H. M. H., & Dutch Covid and Thrombosis Coalition (2026). Inhibition of inflammation reduces hypofibrinolysis in severe COVID-19: A nested case-control study within the MaastrICCht cohort. Thrombosis Research, 262, Article 109723. https://doi.org/10.1016/j.thromres.2026.109723

Cavallari, L. H., Lee, C. R., Beitelshees, A. L., Luzum, J. A., Stouffer, G. A., ten Berg, J. M., van den Broek, W. W. A., Pereira, N. L., Sibbing, D., & Angiolillo, D. J. (2026). 2025 Acute Coronary Syndrome Guideline: Missing the Boat on CYP2C19 Genotyping. Journal of the American Heart Association, 15(10), 1-5. Article e047768. https://doi.org/10.1161/JAHA.125.047768

Galli, M., Pereira, N. L., ten Berg, J., & Angiolillo, D. J. (2026). REPLY: Genotype-Guided vs Conventional Oral P2Y₁₂ Inhibitors in Acute Coronary Syndrome. JACC. Cardiovascular interventions, 19(9), 1193-1193. https://doi.org/10.1016/j.jcin.2026.03.011

Bova, R., Bastings, J., Betti, M., Snik, C., Heuts, S., Segers, P., Winkler, P. J. C., Vriesendorp, P. A., Bidar, E., ten Berg, J. M., Lux, A., van't Hof, A. W. J., & COMMIT LAD Investigators (2026). Design and Rationale of the COMMIT-LAD Registry: A Comprehensive Analysis of Medical and Invasive Treatment Strategies for Patients With Significant Left Anterior Descending Artery Disease (COMMIT-LAD). Journal of Cardiovascular Pharmacology, 87(5), 357-363. https://doi.org/10.1097/FJC.0000000000001799

Hamulyák, E. N., Wang, T. F., Kreuziger, L. B., Iyengar, V., Carney, B. J., Hoeben, A., Özdemir, B. C., Cordova Serrano, R. D., Sanfilippo, K. M., Rozenblatt, S., Beenen, L. F. M., Yust-Katz, S., Halperin, E., Arad, A., Lubetsky, A., Carrier, M., Massat, B., Büller, H. R., Spectre, G., ... ABC Study Group (2026). Intracranial hemorrhage in patients with primary brain cancer receiving anticoagulation. Blood Vessels, Thrombosis & Hemostasis, 3(2), Article 100140. https://doi.org/10.1016/j.bvth.2026.100140

Urlings, E. H., Heubel-Moenen, F. C. J. I., van Oerle, R., Hellenbrand, D. L. S., van der Meijden, P. E. J., Hackeng, T. M., Cate, H. T., Nagy, M., Henskens, Y. M. C., & Spronk, H. M. H. (2026). Intrinsic activated thrombin generation for treatment efficacy and monitoring of octocog alfa and emicizumab in severe hemophilia A. Research and practice in thrombosis and haemostasis, 10(4), Article 106627. https://doi.org/10.1016/j.rpth.2026.106627

Azzahhafi, J., Yin, D. R. P. P. C. P., Epping, M., Bofarid, H., Verhagen, T., Boomars, R., Radstok, A., Houtgraaf, J., van Hout, G. P. J., Bikker, A., & ten Berg, J. M. (2026). Performance of the HEART Score in pre-hospital settings for suspected non-ST-elevation acute coronary syndrome: The POPular HEART Study. Netherlands Heart Journal, 34(5), 179-188. https://doi.org/10.1007/s12471-026-02041-x

Shaw, J. R., Maier, C. L., Hardy, M., Mullier, F., Douxfils, J., Tanaka, K., Rocca, B., ten Cate, H., Kim, P. Y., Carrier, M., Connors, J. M., & Levy, J. H. (2026). Thrombin generation and the pharmacodynamics of parenteral anticoagulants. Pharmacological Reviews, 78(3), Article 100135. https://doi.org/10.1016/j.pharmr.2026.100135

Abels, S., Sihvo, M., Tomppo, L., Kutal, S., Martinez-Majander, N., Tulkki, L., Sarkanen, T., Jakala, P., Redfors, P., Huhtakangas, J., Ylikotila, P., von Sarnowski, B., Yesilot, N., Waje-Andreassen, U., Fonseca, A. C., Martinez Sanchez, P., Korv, J., Ferdinand, P., Ryliskiene, K., ... Putaala, J. (2026). Thrombophilia Screening in Young Patients With Cryptogenic Ischemic Stroke. Stroke, 57(5), 1242-1255. https://doi.org/10.1161/STROKEAHA.125.053251

Magdelijns, F. J. H., de Jong, M. J., Winckers, K., Brys, A. D. H., Braeken, D. C. W., van Kuijk, S. M. J., Spronk, H. M. H., Bosman, H., Janssen, D. J. A., van Geel, R. M. J. M., Hellenbrand, D., ten Cate, H., & Henskens, Y. (2026). Assessing the efficacy of a single-cycle measurement and adjustment strategy for direct oral anticoagulants in frail older patients: rationale and design of the DOAC-FRAIL randomized controlled trial. Research and practice in thrombosis and haemostasis, 10(4), Article 106800. https://doi.org/10.1016/j.rpth.2026.106800

Franssen, I. S., Jong, M. J. D., Vievermans, A., Stroo, J. F., Henskens, Y. M. C., Spronk, H., Janssen, D. J. A., Braeken, D., van Kuijk, S. M. J., Winckers, K., & Magdelijns, F. J. H. (2026). Adequacy of Direct Oral Anticoagulant Dosing in Nursing Home Residents: Cross-Sectional Data From the DOAC-FRAIL Study. Journal of the American Medical Directors Association, 27(4), Article 106082. https://doi.org/10.1016/j.jamda.2025.106082

Gorog, D. A., ten Berg, J. M., Campo, G., Geisler, T., Gigante, B., Grove, E. L., Halvorsen, S., Huber, K., Jeong, Y.-H., Lip, G. Y. H., Navarese, E. P., Rubboli, A., Siller Matula, J. M., Storey, R. F., Valgimigli, M., Vandenbriele, C., Vilahur, G., Ahrens, I., & Ferreiro, J. L. (2026). Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks. European Heart Journal: Acute Cardiovascular Care, 15(4), 337-363. https://doi.org/10.1093/ehjacc/zuag021

Versteeg, G. A. A., Rooijakkers, M. J. P., Hemelrijk, K. I., Vlaar, P. J., Overduin, D. C., van Wely, M. H., Aarts, H. M., van Ginkel, D., Stens, N. A., van Nunen, L. X., van Geuns, R. J., van Garsse, L. A. F. M., Geuzebroek, G. S. C., Verkroost, M. W. A., Cetinyurek-yavuz, A., Heijmen, R. H., Thijssen, D. H. J., ten Berg, J. M., Tonino, P. A. L., ... van Royen, N. (2026). Extremity Function After Transfemoral Transcatheter Aortic Valve Implantation: A TAVI XS Sub-Study. Catheterization and Cardiovascular interventions, 107(5), 1293-1302. https://doi.org/10.1002/ccd.70470

Aarts, A., Brandts, L., Pavlicic, M., Cate, H. T., & ten Cate-Hoek, A. J. (2026). Apixaban vs vitamin K antagonists in relation to postthrombotic syndrome: data from a prospective cohort study. Journal of Thrombosis and Haemostasis, 24(4), 1388-1396. https://doi.org/10.1016/j.jtha.2025.11.022

van Ginkel, D. J., Stragier, H., Bor, W. L., Rosseel, L., Konings, J., Ninivaggi, M., de Simone, I., Huskens, D., Roest, M., van Lenthe, I., Overduin, D. C., Aarnink, E. W., Rooijakkers, M. J. P., Peper, J., Brouwer, J., Nijenhuis, V. J., Rensing, B. J. W. M., Timmers, L., Swaans, M. J., ... ten Berg, J. M. (2026). Effects of continuation versus interruption of oral anticoagulation during transcatheter aortic valve implantation on hemostasis function. Journal of Thrombosis and Haemostasis, 24(4), 1263-1278. https://doi.org/10.1016/j.jtha.2025.11.005

ten Cate, H., & ten Berg, J. (2026). Fibrin clot lysis predicts anticoagulant-associated bleeding in atrial fibrillation: ready for clinical use?European Heart Journal, 47(16), 1961-1963. Article ehaf458. https://doi.org/10.1093/eurheartj/ehaf458

Jacobsen, M. R., Overduin, D. C., Sørensen, R., Andreotti, F., Schulte, C., Huber, K., Clemmensen, P., Trenk, D., Backer, O. D., Aradi, D., Kristensen, S. D., Storey, R. F., Berg, J. M. T., & Geisler, T. (2026). Transcatheter aortic valve thrombosis. Eurointervention, 22(6), 331-346. https://doi.org/10.4244/EIJ-D-25-00512

Willems, R. A. L., van Diepen, A. E., Dekker, E. N., Janssen, Q. P., van Dam, J. L., Michiels, N., van Eijck, C. W. F., Hermans, K. E. P. E., Bonsing, B. A., Bosscha, K. P., Bouwense, S. A. W., Busch, O. R., ten Cate, H., Coene, P.-P. L. O., van Eijck, C. H. J., van Es, N., van der Harst, E., de Hingh, I. H. J. T., Karsten, T. M., ... Dutch Pancreatic Canc Grp (2026). Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 Trial. Journal of Clinical Oncology, 44(8), 662-675. https://doi.org/10.1200/JCO-25-01935

Jmel, M. A., Wu, H., Baaten, C. C. F. M. J., Xu, X., Nandakumar, K. S., & Kotsyfakis, M. (2026). Immunomodulatory Effects of a Tick Salivary Serpin on Psoriasis-like Inflammation. Life, 16(3), Article 427. https://doi.org/10.3390/life16030427

Krommenhoek, J. F., Beekman, W., Kor, F., Gal, P., Berkhout, W. E. M., Meijer, K., Braeken, D. C. W., Klok, F. A., ten Cate, H., & Olie, R. H. (2026). Andexanet alfa for the reversal of anticoagulation: Dutch practice data. Research and practice in thrombosis and haemostasis, 10(3), Article e103438. https://doi.org/10.1016/j.rpth.2026.103438

Aarts, A., ten Cate, H., & ten Cate-Hoek, A. J. (2026). Anticoagulants beyond coagulation: a narrative review of cardiovascular effects. Cardiovascular Research, 122(5), 562-577. https://doi.org/10.1093/cvr/cvag043

Sihvo, M. C., Ylikotila, P., Zedde, M., Pascarella, R., Sarkanen, T., Jatužis, D., Ryliškiene, K., von Sarnowski, B., Licenik, R., Ferdinand, P., Kõrv, J., Kõrv, L., Pezzini, A., Fonseca, A. C., Paula, A., Martínez-Sánchez, P., Yesilot, N., Fromm, A., Waje-Andreassen, U., ... Tomppo, L. (2026). Family history of stroke and cardiovascular diseases in early-onset cryptogenic ischaemic stroke. European Stroke Journal, 11(3), Article aakag013. https://doi.org/10.1093/esj/aakag013

Overduin, D. C., van Ginkel, D. J., Dubois, C., Lesizza, P., Broeze, G. M., Montero-Cabezas, J. M., Rosseel, L., van der Kley, F., van Nuland, P. J., Smits, T. P., Hemelrijk, K. I., Aarts, H. M., Rensing, B. J. W. M., Timmers, L., Swaans, M. J., Sonker, U., Veenstra, L., van't Hof, A. W. J., Peper, J., ... ten Berg, J. M. (2026). Routine versus selective protamine administration to reduce bleeding after TAVI: Rationale and design of the POPular ACE TAVI trial. American Heart Journal, 293, Article 107296. https://doi.org/10.1016/j.ahj.2025.107296

Kempers, E. K., Visser, C., Seelig, J., Chen, Q., Adriaansen, H. J., Beinema, M. J., ten Cate-Hoek, A. J., Faber, L. M., Dronkers, C. E. A., Nierman, M. C., Schindhelm, R. K., Wiersma, N. M., Stork, A. D. M., Klok, F. A., Leebeek, F. W. G., Pisters, R., Cannegieter, S. C., De Caterina, R., Hemels, M. E. W., ... Kruip, M. J. H. A. (2026). Sex differences in outcomes of vitamin K antagonist treatment in patients with a mechanical heart valve: a Dutch population-based cohort study. Journal of Thrombosis and Haemostasis, 24(3), 955-970. https://doi.org/10.1016/j.jtha.2025.09.010

van den Broek, W. W. A., Azzahhafi, J., van de Pol, Q. Y. F., Chan Pin Yin, D. R. P. P., van der Sangen, N. M. R., Sivanesan, S., Peper, J., Harmsze, A. M., Walhout, R. J., Tjon Joe Gin, M., Breet, N. J., Langerveld, J., Appelman, Y., van Schaik, R. H. N., Henriques, J. P. S., Kikkert, W. J., & Ten Berg, J. M. (2026). Genotype-Guided P2Y12-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI. Circulation-Cardiovascular Interventions, 19(5), Article e016084. https://doi.org/10.1161/CIRCINTERVENTIONS.125.016084

ten Cate, V., Sulochana, H. R., ten Cate, H., & Nagy, M. (2026). Coagulation factor XI and cardiovascular disease: A complex, cardio-specific conundrum. Med, 7(2), Article 100995. https://doi.org/10.1016/j.medj.2025.100995

Andreotti, F., O'donoghue, M. L., & Ten Berg, J. (2026). The year in cardiovascular medicine 2025: the top 10 papers in thrombosis and antithrombotic therapy. European Heart Journal, 47(6), 662-665. https://doi.org/10.1093/eurheartj/ehaf1126

Galli, M., Pereira, N. L., Lennon, R. J., van den Broek, W. W. A., Claassens, D. M. F., Bergmeijer, T. O., Rosenberg, Y., Fazzini, L., Deneer, V. H. M., Murad, M. H., Farkouh, M. E., Rihal, C., ten Berg, J., & Angiolillo, D. J. (2026). Genotype-Guided vs Conventional Oral P2Y12 Inhibitors in Acute Coronary Syndrome. JACC. Cardiovascular interventions, 19(3), 283-296. https://doi.org/10.1016/j.jcin.2025.11.029

Galli, M., Ten Berg, J., Valgimigli, M., Capodanno, D., Gragnano, F., Kimura, T., Bhatt, D. L., Gibson, C. M., Mehran, R., & Angiolillo, D. J. (2026). Aspirin or P2Y₁₂ inhibitor monotherapy in atherosclerotic cardiovascular disease?European Heart Journal, 47(5), 558-573. Article ehaf718. https://doi.org/10.1093/eurheartj/ehaf718

Nagy, M., Gomes, T., Van Oerle, R., Hacking, T. M., Magdelijns, F. J. H., Henskens, Y. M. C., Reitsma, P., Short, G., Spronk, H. M. H., & Verhoef, D. (2026). Coagulation assays for assessing the bypassing of factor Xa direct oral anticoagulants using VMX-C001. Research and practice in thrombosis and haemostasis, 10(2), Article e103375. https://doi.org/10.1016/j.rpth.2026.103375

Magdelijns, F. J. H., de Jong, M. J., Winckers, K., Braeken, D. C. W., & Cate, H. T. (2026). Frail older patients and direct oral anticoagulants: trouble in paradise?Journal of Thrombosis and Haemostasis, 24(2), 781-783. https://doi.org/10.1016/j.jtha.2025.10.034

Biguzzi, E., Winckers, K., Hackeng, T. M., Rosendaal, F. R., & Vlieg, A. V. H. (2026). Recurrent venous thromboembolism: association with thrombin generation and d-dimer. Research and practice in thrombosis and haemostasis, 10(2), Article 103391. https://doi.org/10.1016/j.rpth.2026.103391

Sivanesan, S., Gasecka, A., Van Der Sangen, N. M. R., Van Den Broek, W. W. A., Azzahhafi, J., Yin, D. R. P. P. C. P., Van De Pol, Q. Y. F., Walhout, R. J., Gin, M. T. J., Pisters, R., Nicastia, D. M., de Roest, G. J., Vlachojannis, G. J., van Bommel, R. J., Kikkert, W. J., Henriques, J. P. S., ten Berg, J. M., & Appelman, Y. (2026). Sex differences in the presentation and management of acute coronary syndrome patients: Insights from the FORCE-ACS registry. IJC Heart and Vasculature, 62, Article 101849. https://doi.org/10.1016/j.ijcha.2025.101849

Kempers, E. K., Acampo-de Jong, M. J. J., ten Cate, H., De Caterina, R., & Kruip, M. J. H. A. (2026). Timeless therapeutics: cardiac indications for vitamin K antagonists in clinical practice. Heart. https://doi.org/10.1136/heartjnl-2024-324551

Iding, A. F. J., Hupperetz, R. D., Brans, R. J. B., ten Cate, H., van Twist, D. J. L., & ten Cate-Hoek, A. J. (2026). Additional oxerutin therapy to promote deep vein thrombus resolution (RESOLVE-DVT): a randomized controlled pilot trial. Journal of Thrombosis and Haemostasis, 24(2), 644-653. https://doi.org/10.1016/j.jtha.2025.10.018

de Jong, M. J., Brys, A. D. H., Braeken, D., Pisters, R., Janssen, D. J. A., Altintas, S., Robben, S. H. M., Nicolai, S., Eurlings, C., Zwietering, A., De Jonghe, M., Vaes, B., De Backer, T., Grymonprez, M., Joosten, H., ten Cate, H., Winckers, K., & Magdelijns, F. J. H. (2026). Healthcare professionals' perspectives on prescribing DOACs to frail older patients; the DOAC-FRAIL questionnaire. BMC Geriatrics, 26(1), Article 418. https://doi.org/10.1186/s12877-026-06972-3

Jaakonmäki, N., Helin, T., Szanto, T., Zedde, M., Sarkanen, T., Martinez-Majander, N., Sinisalo, J., Junttola, U., Redfors, P., von Sarnowski, B., Waje-Andreassen, U., Ylikotila, P., Yesilot, N., Ryliskiene, K., Tulkki, L., Amaya Pascasio, L., Licenik, R., Ferdinand, P., Gerdts, E., ... SECRETO Study Group (2026). Anti-beta2-glycoprotein I IgG antibodies are associated with early-onset cryptogenic ischemic stroke. European Stroke Journal, 11(1), Article 23969873251351207. https://doi.org/10.1177/23969873251351207

Visser, C., Kempers, E. K., Seelig, J., Chen, Q., Adriaansen, H. J., Beinema, M. J., ten Cate-Hoek, A., Faber, L. M., Klok, F. A., Leebeek, F. W. G., van de Leur, S. J. C. M., Nierman, M. C., Pisters, R., Schindhelm, R. K., Stork, A. D. M., Wiersma, N. M., De Caterina, R., Cannegieter, S. C., Hemels, M. E. W., ... Kruip, M. J. H. A. (2026). Anticoagulation Therapeutic Ranges and Clinical Outcomes in Patients with a Mechanical Heart Valve Treated with Vitamin K Antagonists-a Nationwide Linked-data Dutch Study. Thrombosis and Haemostasis. Advance online publication. https://doi.org/10.1055/a-2773-5810